152 related articles for article (PubMed ID: 29493353)
1. A standardised pathway for the surveillance of stable vestibular schwannoma.
Shapey J; Barkas K; Connor S; Hitchings A; Cheetham H; Thomson S; U-King-Im JM; Beaney R; Jiang D; Barazi S; Obholzer R; Thomas N
Ann R Coll Surg Engl; 2018 Mar; 100(3):216-220. PubMed ID: 29493353
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment.
Bakkouri WE; Kania RE; Guichard JP; Lot G; Herman P; Huy PT
J Neurosurg; 2009 Apr; 110(4):662-9. PubMed ID: 19099381
[TBL] [Abstract][Full Text] [Related]
3. Is There a Need for a 6-Month Postradiosurgery Magnetic Resonance Imaging in the Treatment of Vestibular Schwannoma?
Perry A; Graffeo CS; Carlstrom LP; Hughes JD; Peris-Celda M; Cray NM; Pollock BE; Link MJ
Neurosurgery; 2020 Feb; 86(2):250-256. PubMed ID: 30980077
[TBL] [Abstract][Full Text] [Related]
4. Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.
Lees KA; Tombers NM; Link MJ; Driscoll CL; Neff BA; Van Gompel JJ; Lane JI; Lohse CM; Carlson ML
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):535-542. PubMed ID: 29685084
[TBL] [Abstract][Full Text] [Related]
5. Vestibular schwannoma: role of conservative management.
Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
[TBL] [Abstract][Full Text] [Related]
6. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
7. EAONO position statement on Vestibular Schwannoma: Imaging Assessment Question: How should growth of Vestibular Schwannoma be defined?
Kania R; Vérillaud B; Camous D; Hautefort C; Somers T; Waterval J; Froelich S; Herman P
J Int Adv Otol; 2018 Apr; 14(1):90-94. PubMed ID: 29764781
[TBL] [Abstract][Full Text] [Related]
8. MRI surveillance of vestibular schwannomas without contrast enhancement: Clinical and economic evaluation.
Coelho DH; Tang Y; Suddarth B; Mamdani M
Laryngoscope; 2018 Jan; 128(1):202-209. PubMed ID: 28397265
[TBL] [Abstract][Full Text] [Related]
9. A cost effective screening protocol for vestibular schwannoma in the late 90s.
Ravi KV; Wells SC
J Laryngol Otol; 1996 Dec; 110(12):1129-32. PubMed ID: 9015424
[TBL] [Abstract][Full Text] [Related]
10. Vestibular schwannoma: natural growth and possible predictive factors.
D'Haese S; Parmentier H; Keppler H; Van Vooren S; Van Driessche V; Bauters W; Van Roost D; Dhooge I
Acta Otolaryngol; 2019 Sep; 139(9):753-758. PubMed ID: 31282832
[No Abstract] [Full Text] [Related]
11. Cost analysis of vestibular schwannoma screening with contrast-enhanced magnetic resonance imaging in patients with asymmetrical hearing loss.
Pan P; Huang J; Morioka C; Hathout G; El-Saden SM
J Laryngol Otol; 2016 Jan; 130(1):21-4. PubMed ID: 26365591
[TBL] [Abstract][Full Text] [Related]
12. Conservative management of vestibular schwannoma.
González-Orús Álvarez-Morujo RJ; Alvarez-Palacios I; Martin-Oviedo C; Scola-Yurrita B; Arístegui-Ruiz MÁ
Acta Otorrinolaringol Esp; 2014; 65(5):275-82. PubMed ID: 24930856
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous tumour shrinkage in 1261 observed patients with sporadic vestibular schwannoma.
Huang X; Caye-Thomasen P; Stangerup SE
J Laryngol Otol; 2013 Aug; 127(8):739-43. PubMed ID: 23866680
[TBL] [Abstract][Full Text] [Related]
14. The Conditional Probability of Vestibular Schwannoma Growth at Different Time Points After Initial Stability on an Observational Protocol.
Sethi M; Borsetto D; Cho Y; Gair J; Gamazo N; Jefferies S; Joannides A; Mannion R; Helmy A; Axon P; Donnelly N; Tysome JR; Bance M
Otol Neurotol; 2020 Feb; 41(2):250-257. PubMed ID: 31613836
[TBL] [Abstract][Full Text] [Related]
15. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
[TBL] [Abstract][Full Text] [Related]
16. A large vestibular schwannoma that did not grow for 18 years.
Timmer FC; Graamans K
B-ENT; 2011; 7(4):305-7. PubMed ID: 22338247
[TBL] [Abstract][Full Text] [Related]
17. The natural history of vestibular schwannoma.
Stangerup SE; Caye-Thomasen P; Tos M; Thomsen J
Otol Neurotol; 2006 Jun; 27(4):547-52. PubMed ID: 16791048
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of a non-contrast screening MRI protocol for vestibular schwannoma in patients with asymmetric sensorineural hearing loss.
Crowson MG; Rocke DJ; Hoang JK; Weissman JL; Kaylie DM
Neuroradiology; 2017 Aug; 59(8):727-736. PubMed ID: 28623482
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cost effectiveness for conservative and active management strategies for acoustic neuroma.
Verma S; Anthony R; Tsai V; Taplin M; Rutka J
Clin Otolaryngol; 2009 Oct; 34(5):438-46. PubMed ID: 19793276
[TBL] [Abstract][Full Text] [Related]
20. The role of conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
Clin Otolaryngol Allied Sci; 2000 Feb; 25(1):28-39. PubMed ID: 10764234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
